Healthcare Triangle Enters Neurotechnology AI Devices and Solutions for Southeast Asia
Healthcare Triangle is launching Neurotechnology AI Devices Sales and Solutions through its subsidiary Quantum Nexis, targeting brain-health and mental-health care in Malaysia and Indonesia, a combined population of over 310 million. The initiative spans three revenue streams: device sales and servicing, training and certification via a Quantum Nexis academy, and recurring AI-enabled software subscriptions for clinics. First regulatory submission to Malaysia's Medical Device Authority is planned for Q1 2027, with first locally assembled devices targeted for Q3 2027.
Key figures
- Market cagr
- 12.2%
- First devices
- Q3 2027
- Market size 2024
- US$15.2 billion global neurotech devices market (2024)
- Market size 2030
- US$30.3 billion global neurotech devices market (2030)
- Target population
- Malaysia and Indonesia, more than 310 million people
- Regulatory submission
- Q1 2027 (Malaysia Medical Device Authority)
- Apac mental health growth
- 13.2% annual growth 2024-2030
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.